Homocysteine induced a calcium-mediated disruption of mitochondrial function and dynamics in endothelial cells

Homocysteine (Hcy) is a sulfur-containing amino acid that originated in methionine metabolism and the elevated level of Hcy in plasma is considered to be an independent risk factor for cardiovascular diseases (CVD). Endothelial dysfunction plays a major role in the development of CVD, while the potential mechanism of Hcy-induced endothelial dysfunction is still unclear. Here, in Hcy-treated endothelial cells, we observed the destruction of mitochondrial morphology and the decline of mitochondrial membrane potential. Meanwhile, the level of ATP was reduced and the reactive oxygen species was increased. The expressions of dynamin-related protein 1 (Drp1) and phosphate-Drp1 (Ser616) were upregulated, whereas the expression of mitofusin 2 was inhibited by Hcy treatment. These findings suggested that Hcy not only triggered mitochondrial dysfunction but also incurred an imbalance of mitochondrial dynamics in endothelial cells. The expression of mitochondrial calcium uniporter (MCU) was activated by Hcy, contributing to calcium transferring into mitochondria. Interestingly, the formation of mitochondria-associated membranes (MAMs) was increased in endothelial cells after Hcy administration. The inositol 1,4,5-triphosphate receptor (IP3R)-glucose-regulated protein 75 (Grp75)-voltage-dependent anion channel (VDAC) complex, which was enriched in MAMs, was also increased. The accumulation of mitochondrial calcium could be blocked by inhibiting with the IP3R inhibitor Xestospongin C (XeC) in Hcy-treated cells. Then, we confirmed that the mitochondrial dysfunction and the increased mitochondrial fission induced by Hcy could be attenuated after Hcy and XeC co-treatment. In conclusion, Hcy-induced mitochondrial dysfunction and dynamics disorder in endothelial cells were mainly related to the increase of calcium as a result of the upregulated expressions of the MCU and the IP3R-Grp75-VDAC complex in MAMs.

Effect of renin-angiotensin-aldosterone system inhibitors on all-cause mortality and major cardiovascular events in patients with diabetes: A meta-analysis focusing on the number needed to treat and minimal clinical effect

AIMS

To assess the effectiveness of renin-angiotensin-aldosterone system (RAAS) inhibitors, angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) separately to prevent all-cause mortality, myocardial infarction (MI), stroke and heart failure (HF) in patients with diabetes considering the number needed to treat (NNT) and minimal clinical effect (MCE).

METHODS

Data from 17 morbidity-mortality trials in patients with diabetes were used to calculate NNTs and evaluate MCE to prevent all-cause mortality, myocardial infarction, stroke, and heart failure.

RESULTS

A total of 17 trials involving 42,037 patients were included in this meta-analysis. Mean follow-up was 3.7 years. ACEIs significantly reduced the risk of all-cause mortality, MI and HF; the corresponding mean NNTBs were 48, 62 and 78, respectively, but ARBs were only associated with a reduction in heart failure. The clinical significance assessment of the included trials indicated that most of the statistically significant trial results had no definitive clinical significance, and only some of them had possible clinical significance.

CONCLUSIONS

Among patients with diabetes, ACEIs reduced all-cause mortality, MI and HF, whereas ARBs could only prevent HF. However, none of the results of these trials had clear clinical significance, and most had only possible clinical significance.

Phase-field-simplified lattice Boltzmann method for modeling solid-liquid phase change

This article proposes a phase-field-simplified lattice Boltzmann method (PF-SLBM) for modeling solid-liquid phase change problems within a pure material. The PF-SLBM consolidates the simplified lattice Boltzmann method (SLBM) as the flow solver and the phase-field method as the interface tracking algorithm. Compared with conventional lattice Boltzmann modelings, the SLBM shows advantages in memory cost, boundary treatment, and numerical stability, and thus is more suitable for the present topic which includes complex flow patterns and fluid-solid boundaries. In contrast to the sharp interface approach, the phase-field method utilized in this work represents a diffuse interface strategy and is more flexible in describing complicated fluid-solid interfaces. Through abundant benchmark tests, comprehensive validations of the accuracy, stability, and boundary treatment of the proposed PF-SLBM are carried out. The method is then applied to the simulations of partially melted or frozen cavities, which sheds light on the potential of the PF-SLBM in resolving practical problems.

Perfluorooctane sulfonate induced toxicity in embryonic stem cell-derived cardiomyocytes via inhibiting autophagy-lysosome pathway

Perfluorooctane sulfonate (PFOS), a classic environmental pollutant, is reported to cause cardiotoxicity in animals and humans. It has been demonstrated that PFOS exposure down-regulates expression of cardiac-development related genes and proteins. However, the related mechanism of PFOS has not been fully elucidated. In the present study, the embryonic stem (ES) cells-derived cardiomyocytes (ESC-CMs) was employed to investigate PFOS-mediated mechanism in developmental toxicity of cardiomyocytes. Our previous study shows that PFOS induces cardiomyocyte toxicity via causing mitochondrial damage. Nevertheless, the underlying mechanism by which PFOS affects the autophagy-related mitochondrial toxicity in ESC-CMs remains unclear. Here, we found that PFOS induced the swelling of mitochondria and the autophagosome accumulation in ESC-CMs at 40 μM concentration. PFOS increased the levels of LC3-II, p62, and ubiquitinated proteins. PFOS also induced an increase of LC3 and p62 localization into mitochondria, indicating that mitophagy degradation was impaired. The results of autophagic flux using chloroquine and RFP-GFP-LC3 analysis showed that the accumulation of autophagosome was not caused by the formation but by the impaired degradation. PFOS was capable of blocking the fusion between autophagosome and lysosome. PFOS caused dysfunction of lysosomes because it down-regulated Lamp2a and cathepsin D, but it did not induced lysosome membrane permeabilization. Meanwhile, PFOS-mediated lysosomal function and the inhibitory effect of autophagic flux could be reversed by PP242 at 40 nM concentration, an mTOR inhibitor. Furthermore, PP242 restored PFOS-induced ATP depletion and mitochondrial membrane potential. In conclusion, PFOS induced mitochondrial dysfunction via blocking autophagy-lysosome degradation, leading to cardiomyocyte toxicity from ES cells.

A critical study of the generality of the two step two electron pathway for water splitting by application of a C3N4/MnO2 photocatalyst

A novel C3N4-CDot composite photocatalyst was very recently shown to be highly efficient and very stable in water splitting by solar radiation without using any sacrificial reagent (J. Liu, et al., Science, 2015, 347(6225), 970). This photocatalyst utilizes a two-electron/two-step process in which the production of H2O2 and H2 is photocatalyzed by using C3N4 in the first step and H2O2 is decomposed by using CDots in the second step. The present work is a study on the generality of this approach by application of a C3N4/MnO2 catalyst. This new catalyst indeed splits water by a two step process in a stable way, without any sacrificial agent. It was however found that though the absorbance of the new catalyst in the visible range of 500-600 nm is much larger than that of the C3N4-CDot catalyst, its water splitting efficiency is much lower. These findings add insight into and assist in the further optimization of this new class of photocatalysts to meet the requirements of commercial water splitting systems.

HLA-DQ association and allele competition in Chinese narcolepsy

In Japanese, Koreans and Caucasians, narcolepsy/hypocretin deficiency is tightly associated with the DRB1*15:01-DQA1*01:02-DQB1*06:02 haplotype. Studies in African-Americans suggest a primary effect of DQB1*06:02, but this observation has been difficult to confirm in other populations because of high linkage disequilibrium between DRB1*15:01/3 and DQB1*06:02 in most populations. In this study, we studied human leucocyte antigen (HLA) class II in 202 Chinese narcolepsy patients (11% from South China) and found all patients to be DQB1*06:02 positive. Comparing cases with 103 unselected controls, and 110 and 79 controls selected for the presence of DQB1*06:02 and DRB1*15:01, we found that the presence of DQB1*06:02 and not DRB1*15:01 was associated with narcolepsy. In particular, Southern Chinese haplotypes such as the DRB1*15:01-DQA1*01:02-DQB1*06:01 and DRB1*15:01-DQA1*01:02-DQB1*05 were not associated with narcolepsy. As reported in Japanese, Koreans, African-Americans and Caucasians, additional protective effects of DQA1*01 (non-DQA1*01:02) and susceptibility effects of DQB1*03:01 were observed. These results illustrate the extraordinary conservation of HLA class II effects in narcolepsy across populations and show that DRB1*15:01 has no effect on narcolepsy susceptibility in the absence of DQB1*06:02. The results are also in line with a previously proposed 'HLA-DQ allelic competition model' that involves competition between non-DQA1*01:02, non-DQB1*06:02 'competent' (able to dimerize together) DQ1 alleles and the major DQα*01:02/ DQβ*06:02 narcolepsy heterodimer to reduce susceptibility.

The axr6 mutants of Arabidopsis thaliana define a gene involved in auxin response and early development

The indolic compound auxin regulates virtually every aspect of plant growth and development, but its role in embryogenesis and its molecular mechanism of action are not understood. We describe two mutants of Arabidopsis that define a novel gene called AUXIN-RESISTANT6 (AXR6) which maps to chromosome 4. Embryonic development of the homozygous axr6 mutants is disrupted by aberrant patterns of cell division, leading to defects in the cells of the suspensor, root and hypocotyl precursors, and provasculature. The homozygous axr6 mutants arrest growth soon after germination lacking a root and hypocotyl and with severe vascular pattern defects in their cotyledons. Whereas previously described mutants with similar developmental defects are completely recessive, axr6 heterozygotes display a variety of morphological and physiological alterations that are most consistent with a defect in auxin physiology or response. The AXR6 gene is likely to be important for auxin response throughout the plant, including early development.

Inhibitory anti-CYP3A4 peptide antibody: mapping of inhibitory epitope and specificity toward other CYP3A isoforms

An antipeptide antibody has been produced that recognizes CYP3A4 and exhibits greater than 90-95% inhibition on CYP3A4-mediated reactions [Wang RW and Lu AYH (1997) Drug Metab Dispos 25:762-767]. The inhibitory epitope of the 21-amino acid peptide, corresponding to residues 253 to 273 of CYP3A4, has been identified to reside in a 7-amino acid sequence (LEDTQKH: residues 261-267 of CYP3A4). This conclusion was based on the reversal of antibody inhibition of testosterone 6beta-hydroxylation when peptides with overlapping sequence in this region were preincubated with the antibody. In immunoblotting analysis, this antibody did not recognize CYP3A5 or CYP3A7 in microsomes prepared from baculovirus-infected cells containing these two expressed isoforms. In addition, the antipeptide antibody did not inhibit testosterone 6beta-hydroxylation or midazolam 1'- and 4-hydroxylation in microsomes containing expressed CYP3A5 and CYP3A7. Because the corresponding sequence in CYP3A5 (LNDKQKH) and CYP3A7 (LKETQKH) differs from CYP3A4 by only two amino acids, six peptides with either one or two amino acid changes were used to determine which amino acid is essential for antibody-antigen interaction. Our data indicate that Glu, Asp, and Thr in the 7-amino acid sequence of CYP3A4 are critical determinants of selectivity among CYP3A isoforms.

gamma-Linolenic acid treatment of rheumatoid arthritis. A randomized, placebo-controlled trial

OBJECTIVE

To assess the clinical efficacy and adverse effects of gamma-linolenic acid (GLA), a plant seed oil-derived unsaturated fatty acid that suppresses inflammation and joint tissue injury in animal models, in the treatment of active rheumatoid arthritis (RA).

METHODS

Fifty-six patients with active RA were randomized to treatment groups in a 6-month, double-blind trial of GLA versus placebo. This was followed by a 6-month, single-blind trial during which all patients received GLA. Patients were treated with 2.8 gm/day of GLA as the free fatty acid or with sunflower seed oil (placebo) administered in identical capsules.

RESULTS

Treatment with GLA for 6 months resulted in statistically significant and clinically relevant reductions in the signs and symptoms of disease activity in patients with RA. Overall meaningful responses (at least 25% improvement in 4 measures) were also better in the GLA treatment group (14 of 22 patients versus 4 of 19 in the placebo group; P = 0.015). During the second 6 months, both groups exhibited improvement in disease activity. Thus, patients taking GLA during the entire study showed progressive improvement during the second 6 months. In this group, 16 of 21 patients showed meaningful improvement at 12 months compared with study entry.

CONCLUSION

GLA at doses used in this study is a well-tolerated and effective treatment for active RA. GLA is available as a component of several plant seed oils and is usually taken in far lower doses than were used in this trial. It is not approved in the United States for the treatment of any condition, and should not be viewed as therapy for any disease. Further controlled studies of its in RA are warranted.

Treatment of Lyme arthritis

OBJECTIVE

To test treatment regimens for Lyme arthritis.

METHODS

Patients were randomly assigned to treatment with doxycycline or amoxicillin plus probenecid for 30 days. Patients who had persistent arthritis for at least 3 months after treatment with oral antibiotics or parenteral penicillin were given intravenous ceftriaxone for 2 weeks.

RESULTS

Eighteen of the 20 patients treated with doxycycline and 16 of the 18 patients who completed the amoxicillin regimen had resolution of the arthritis within 1-3 months after study entry. However, neuroborreliosis later developed in 5 patients, 4 of whom had received the amoxicillin regimen. Of 16 patients (2 from the oral antibiotic study and 14 additional patients) who had persistent arthritis despite previous oral antibiotics or parenteral penicillin, none had resolution of the arthritis within 3 months after ceftriaxone therapy. The HLA-DR4 specificity and OspA reactivity were associated with a lack of response.

CONCLUSION

Lyme arthritis can usually be treated successfully with oral antibiotics, but patients may still develop neuroborreliosis. Patients with certain genetic and immune markers may have persistent arthritis despite treatment with oral or intravenous antibiotics.

Chronic inflammatory arthritis after treatment with high-dose interleukin-2 for malignancy

Interleukin-2 (IL-2) immunotherapy resulted in the development of inflammatory arthritis in three male patients with metastatic cancer. Two patients developed a clinical picture consistent with rheumatoid arthritis. A third patient with a remote history of Reiter's syndrome developed a recrudescence of an inflammatory arthritis after treatment with IL-2. The clinical, laboratory, and histologic data on the patients and the potential pathophysiologic mechanisms are discussed.

Body composition and sexual maturation in premenarcheal athletes and nonathletes

The purpose of this study was to compare premenarcheal athletes (A) and nonathletes (NA) in terms of body composition and sexual maturation and to discern the relationship between these variables. Percent body fat (%BF) was determined by the three-component system of Siri utilizing body density from hydrostatic weighing and total body water measured by deuterium oxide dilution. Sexual maturation was self-assessed using the system described by Marshall and Tanner. ANOVAs and polynomial regression analysis revealed that both the A (N = 73) and NA (N = 53) showed similar values and linear increases (P less than 0.001) in height (HT), weight (WT), breast (B) and pubic hair (PH) development from 7 to 15 yr but not in %BF (XA = 15.7 +/- 4.6; XNA = 20.5 +/- 6.4 (P less than 0.001]. The NA exhibited a quadratic curve (P less than 0.01) in %BF over age, while the A showed a negative linear relationship (P less than 0.001) with age. Scheffe post hoc tests revealed significant differences (P less than 0.03, A less than NA) at 11 and 12-15 yr. When %BF was compared to maturation, the A were found to have less fat (P less than 0.01) at stages 1 and 4 of PH and at stages 2, 3, and 4 of B. There were no significant differences between A and NA in the age at which B2, 3, or 4 or PH2, 3, or 4 occurred. Both groups exhibited similar and significant correlations between age, HT, WT, B, and PH development but not %BF.(ABSTRACT TRUNCATED AT 250 WORDS)

Somatotypes of premenarcheal athletes and non-athletes

One-hundred thirty-four premenarcheal girls between the ages of 7 and 15 years were somatotyped according to the Health-Carter technique. Sexual maturation was determined by self-assessed Tanner stages. Statistical analysis was completed on 50 athletes (representing seven sports) and 29 non-athletes over the age of 10 years. The mean somatotype for the athletes was calculated to be 2.4-3.6-3.9 and for the non-athletes 3.7-3.7-3.6. Single component ANOVA's revealed that the athletes were significantly less endomorphic (p less than 0.01) than the non-athletes. The overall somatotype ratings and the equality of dispersion about the means were significantly different between the athletes and non-athletes. The single highest category for the athletes was mesomorph-ectomorph and for the non-athletes, mesomorphic-endomorph. Significant negative correlations were obtained between mesomorphy and breast development (-0.33, p less than 0.05) and mesomorphy and pubic hair development (-0.44, p less than 0.01) for the athletes. Significant positive correlations were obtained between endomorphy and breast development (0.55, p less than 0.01) and endomorphy and pubic hair development (0.45, p less than 0.05) for the non-athletes. The mean somatotype for the gymnasts was 2.1-3.9-3.6 and for the swimmers 2.5-3.4-4.1. These two groups were significantly different from each other on each separate component and overall somatotype, but not in equality of dispersion. The results support the conclusion that premenarcheal athletes are morphologically different from non-athletes despite their youth and from each other based on sport specificity.